Abstract
Data regarding coronavirus disease (COVID-19) infection complications among people with HIV (PWH) are expanding but sometimes conflicting. This report presents the results of a retrospective review of 103 patients at a single urban academic health center with confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The study showed that hospitalization is related to host factors such as age 65 years or older with an increasing number of specific non-communicable disease comorbidities, and not to HIV-attributable factors.
Competing Interest Statement
The spouse of Sheela Shenoi worked for Merck Pharmaceuticals from 1997 to 2007 and retains company stock in his retirement account. While no conflict of interest is involved this information is included here in the interest of full disclosure. All other authors report no potential conflicts of interest.
Funding Statement
Financial Disclosures Sheela Shenoi received support from the Doris Duke Charitable Foundation (#201516).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by the Yale University Institutional Review Board and the requirement for an informed consent was waived for this retrospective review. All patient records and pertinent information were de-identified prior to the analysis.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
All authors contributed significantly to the study design and to the collection, organization, and analysis of the data, and participated in the preparation of this report. The authors have approved the final version for submission.
Data Availability
All data referred to in the manuscript is available for review.
